{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:39:12Z","timestamp":1792539552927,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e00973","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:04:14Z","timestamp":1784628254000},"page":"e00973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The real-world safety profile of amitriptyline: A comprehensive pharmacovigilance analysis based on the large-scale FDA adverse event reporting system database"],"prefix":"10.1016","volume":"23","author":[{"given":"Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neurot.2026.e00973_bib1","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/jnc.16097","article-title":"The role of serotonin in depression-A historical roundup and future directions","volume":"168","author":"Bremshey","year":"2024","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00973_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.psc.2023.02.001","article-title":"The individual and societal burden of treatment-resistant depression: an overview","volume":"46","author":"Baig-Ward","year":"2023","journal-title":"Psychiatr Clin North Am"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00973_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.2024.5756","article-title":"Management of depression in adults: a review","volume":"332","author":"Simon","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.neurot.2026.e00973_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euroneuro.2023.11.005","article-title":"Cognitive functioning in children and adolescents with depression: a systematic review and meta-analysis","volume":"79","author":"Schumacher","year":"2024","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00973_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/cns.12854","article-title":"Anhedonia in depression and schizophrenia: a transdiagnostic challenge","volume":"24","author":"Lambert","year":"2018","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neurot.2026.e00973_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2017.06.009","article-title":"Multimorbidity and depression: a systematic review and meta-analysis","volume":"221","author":"Read","year":"2017","journal-title":"J Affect Disord"},{"key":"10.1016\/j.neurot.2026.e00973_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.euroneuro.2022.10.001","article-title":"Excess resource use and costs of physical comorbidities in individuals with mental health disorders: a systematic literature review and meta-analysis","volume":"66","author":"Simon","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neurot.2026.e00973_bib8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jad.2025.03.007","article-title":"Post-marketing safety evaluation of Vortioxetine: a decade-long pharmacovigilance study based on the FAERS database","volume":"379","author":"Wu","year":"2025","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00973_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1021\/acschemneuro.0c00467","article-title":"Classics in chemical neuroscience: amitriptyline","volume":"12","author":"McClure","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00973_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70460","article-title":"Comparison of duloxetine supplemented with pregabalin and amitriptyline supplemented with pregabalin for the treatment of postherpetic neuralgia: a double-blind, randomized crossover trial","volume":"31","author":"Wang","year":"2025","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00973_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ph16071047","article-title":"Global research trends and hotspots analysis of the scientific production of amitriptyline: a bibliometric approach","volume":"16","author":"Pereira","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41380-022-01824-z","article-title":"Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis","volume":"28","author":"Kishi","year":"2023","journal-title":"Mol Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2023-300730","article-title":"Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis","volume":"27","author":"Kamp","year":"2024","journal-title":"BMJ Ment Health"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00973_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1557988317734519","article-title":"Amitriptyline and sexual function: a systematic review updated for sexual health practice","volume":"12","author":"Chen","year":"2018","journal-title":"Am J Mens Health"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00973_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284168","article-title":"Amitriptyline\u2019s anticholinergic adverse drug reactions-A systematic multiple-indication review and meta-analysis","volume":"18","author":"Brueckle","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e00973_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.121240","article-title":"Adverse events related to buspirone: a real-world pharmacovigilance study using the FAERS database","volume":"401","author":"Wen","year":"2026","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00973_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cns.70836","article-title":"The real-world safety profile of temazepam: a 20-Year pharmacovigilance analysis based on the large-scale FAERS database","volume":"32","author":"Wen","year":"2026","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00973_bib18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00973_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7150\/ijms.7967","article-title":"Commonality of drug-associated adverse events detected by 4 commonly used data mining algorithms","volume":"11","author":"Sakaeda","year":"2014","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.neurot.2026.e00973_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fpsyt.2017.00108","article-title":"Sex differences in the peripheral immune system in patients with depression","volume":"8","author":"Birur","year":"2017","journal-title":"Front Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/ejn.14547","article-title":"Neurobiology of resilience in depression: immune and vascular insights from human and animal studies","volume":"53","author":"Dudek","year":"2021","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neurot.2026.e00973_bib22","doi-asserted-by":"crossref","DOI":"10.2196\/46538","article-title":"Challenges and implications for menopausal health and help-seeking behaviors in midlife women from the United States and China in light of the COVID-19 pandemic: web-based panel surveys","volume":"10","author":"Lau","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.neurot.2026.e00973_bib23","series-title":"Medical genetics summaries","article-title":"Amitriptyline therapy and CYP2D6 and CYP2C19 genotype","author":"Dean","year":"2012"},{"key":"10.1016\/j.neurot.2026.e00973_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1136557","article-title":"Depression symptoms, anxiety, and stress among undergraduate entrance admission seeking students in Bangladesh: a cross-sectional study","volume":"11","author":"Rabby","year":"2023","journal-title":"Front Public Health"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00973_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamapediatrics.2023.0846","article-title":"Changes in depression and anxiety among children and adolescents from before to during the COVID-19 pandemic: a systematic review and meta-analysis","volume":"177","author":"Madigan","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00973_bib26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00787-021-01744-3","article-title":"Mostly worse, occasionally better: impact of COVID-19 pandemic on the mental health of Canadian children and adolescents","volume":"31","author":"Cost","year":"2022","journal-title":"Eur Child Adolesc Psychiatr"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00973_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1024\/1422-4917\/a000196","article-title":"[The psychopharmacological treatment of depressive disorders in childhood and adolescence - developments and standards since the \u00abblack box\u00bb warning]","volume":"40","author":"Plener","year":"2012","journal-title":"Z Kinder JugenPsychiatr Psychother"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.2760","article-title":"Relationship between suicide rate and antidepressant prescription: an ecological study in the People\u2019s Republic of China","volume":"36","author":"Xin","year":"2021","journal-title":"Hum Psychopharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00973_bib29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2215-0366(16)30030-X","article-title":"Suicide prevention strategies revisited: 10-year systematic review","volume":"3","author":"Zalsman","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neurot.2026.e00973_bib30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fpsyt.2020.00717","article-title":"Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment","volume":"11","author":"Boaden","year":"2020","journal-title":"Front Psychiatr"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00973_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neurot.2026.e00973_bib32","article-title":"Risk of suicidal behaviors and antidepressant exposure among children and adolescents: a meta-analysis of observational studies","volume":"13","author":"Li","year":"2022","journal-title":"Front Psychiatr"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00973_bib33","first-page":"50","article-title":"Antidepressant-induced activation in children and adolescents: risk, recognition and management","volume":"48","author":"Luft","year":"2018","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00973_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2344\/anpr-64-04-14","article-title":"Anesthetic considerations for patients on antidepressant therapy-part I","volume":"64","author":"Saraghi","year":"2017","journal-title":"Anesth Prog"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00973_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14060383","article-title":"Treatment of depression with botulinum toxin","volume":"14","author":"Wollmer","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.neurot.2026.e00973_bib36","volume":"122","author":"Hallengren","year":"2025","journal-title":"Lakartidningen"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00973_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/WNF.0000000000000337","article-title":"Nortriptyline abuse: a case report and review of the literature","volume":"42","author":"Miller","year":"2019","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00973_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/JCP.0000000000002073","article-title":"Anticholinergic equivalence in psychotropic medications: a guide for psychiatrists","volume":"45","author":"Badre","year":"2025","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.neurot.2026.e00973_bib39","article-title":"Amitriptyline dependence and its associations: a case report and literature review","volume":"2021","author":"Umaharan","year":"2021","journal-title":"Case Rep Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56072-z","article-title":"Dual action of amitriptyline on NMDA receptors: enhancement of Ca-dependent desensitization and trapping channel block","volume":"9","author":"Stepanenko","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e00973_bib41","article-title":"Tricyclic antidepressant structure-related alterations in calcium-dependent inhibition and open-channel block of NMDA receptors","volume":"12","author":"Stepanenko","year":"2021","journal-title":"Front Pharmacol"},{"issue":"24","key":"10.1016\/j.neurot.2026.e00973_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416177","article-title":"Calcium-dependent interplay of lithium and tricyclic antidepressants, amitriptyline and desipramine, on N-methyl-D-aspartate receptors","volume":"23","author":"Boikov","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00973_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1292\/jvms.22-0494","article-title":"Amitriptyline intoxication in bullfrogs causes widening of QRS complexes in electrocardiogram","volume":"85","author":"Nagano","year":"2023","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.neurot.2026.e00973_bib44","first-page":"35","article-title":"Electrocardiogram abnormality in poisoned patients with tricyclic antidepressant","volume":"38","author":"Javadipour","year":"2024","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.neurot.2026.e00973_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/20451253241243297","article-title":"The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use","volume":"14","author":"Taylor","year":"2024","journal-title":"Ther Adv Psychopharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1124\/mol.108.051490","article-title":"Amitriptyline activates cardiac ryanodine channels and causes spontaneous sarcoplasmic reticulum calcium release","volume":"75","author":"Chopra","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00973_bib47","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.tips.2017.06.004","article-title":"Towards a structural view of drug binding to hERG K(+) channels","volume":"38","author":"Vandenberg","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00228-019-02766-2","article-title":"Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients","volume":"76","author":"Scherf-Clavel","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00973_bib49","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s44197-024-00223-7","article-title":"Antenatal depression and its associated factors: findings from Kuwait birth cohort study","volume":"14","author":"Al-Sabah","year":"2024","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib50","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2493","article-title":"Prenatal antidepressant use and risk of adverse neonatal outcomes","volume":"146","author":"Bandoli","year":"2020","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00973_bib51","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.4088\/JCP.12r07967","article-title":"The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013372","article-title":"Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec pregnancy cohort","volume":"7","author":"B\u00e9rard","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.neurot.2026.e00973_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxlet.2017.08.012","article-title":"Impact of selective serotonin reuptake inhibitors on neural crest stem cell formation","volume":"281","author":"Vichier-Guerre","year":"2017","journal-title":"Toxicol Lett"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00973_bib54","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/biolre\/ioz204","article-title":"Placental serotonin signaling, pregnancy outcomes, and regulation of fetal brain development","volume":"102","author":"Rosenfeld","year":"2020","journal-title":"Biol Reprod"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00973_bib55","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/AOG.0000000000004538","article-title":"Associations between maternal depression, antidepressant use during pregnancy, and adverse pregnancy outcomes: an individual participant data meta-analysis","volume":"138","author":"Vlenterie","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00973_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/pme-2021-0022","article-title":"The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites","volume":"19","author":"Mifsud","year":"2022","journal-title":"Per Med"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00973_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14041208","article-title":"The assessment of the safety profile of selective serotonin reuptake inhibitors versus other antidepressants: drug-drug interaction insights from EudraVigilance","volume":"14","author":"Dobrea","year":"2025","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00973_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5055\/jom.0907","article-title":"Urinary metabolic ratio of pain management and substance abuse treatment drugs: drug-Drug interactions","volume":"21","author":"Cua","year":"2025","journal-title":"J Opioid Manag"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00973_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.neurot.2026.e00973_bib60","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8748","article-title":"Association of sleep among 30 antidepressants: a population-wide adverse drug reaction study, 2004-2019","volume":"8","author":"Eugene","year":"2020","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00973_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2209736","article-title":"Association between anticholinergic medication uses and the risk of pneumonia in elderly adults: a meta-analysis and systematic review","volume":"55","author":"Wu","year":"2023","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00973_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2025.100507","article-title":"Anticholinergic drug exposure is associated with prevalence, worsening and incidence of dysphagia among hospitalized older adults","volume":"29","author":"Muglia","year":"2025","journal-title":"J Nutr Health Aging"},{"issue":"17","key":"10.1016\/j.neurot.2026.e00973_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17176260","article-title":"The prevalence of anticholinergic drugs and correlation with pneumonia in elderly patients: a population-based study in Taiwan","volume":"17","author":"Lee","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00973_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/nu14102121","article-title":"Anticholinergic load is associated with swallowing dysfunction in convalescent older patients after a stroke","volume":"14","author":"Kose","year":"2022","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00973_bib65","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1111\/jgs.15066","article-title":"Antipsychotics and the risk of aspiration pneumonia in individuals hospitalized for nonpsychiatric conditions: a cohort study","volume":"65","author":"Herzig","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00973_bib66","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jgs.13327","article-title":"Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study","volume":"63","author":"Paul","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.neurot.2026.e00973_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2024.100192","article-title":"The relationship between gender and pharmacology","volume":"7","author":"Younes","year":"2024","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00973_bib68","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1007\/s00210-025-04721-8","article-title":"Biological sex differences in pharmacokinetics and adverse drug reactions","volume":"399","author":"Aljohmani","year":"2026","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00973_bib69","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1037\/bul0000102","article-title":"Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms","volume":"143","author":"Salk","year":"2017","journal-title":"Psychol Bull"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00973_bib70","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s002130000597","article-title":"Transplacental transfer of amitriptyline and nortriptyline in isolated perfused human placenta","volume":"153","author":"Heikkinen","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00973_bib71","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5152\/alphapsychiatry.2021.21143","article-title":"The relationship between maternal antidepressants and neonatal hypoglycemia: a systematic review","volume":"22","author":"Uguz","year":"2021","journal-title":"Alpha Psychiatr"},{"key":"10.1016\/j.neurot.2026.e00973_bib72","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fnins.2019.01309","article-title":"Anticholinergic drugs in geriatric psychopharmacology","volume":"13","author":"L\u00f3pez-\u00c1lvarez","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurot.2026.e00973_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.889088","article-title":"Generalised weibull model-based approaches to detect non-constant hazard to signal adverse drug reactions in longitudinal data","volume":"13","author":"Sauzet","year":"2022","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00973_bib74","article-title":"Amitriptyline versus placebo for major depressive disorder","volume":"12","author":"Leucht","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00973_bib75","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1080\/14740338.2024.2309223","article-title":"Utilizing temporal pattern of adverse event reports to identify potential late-onset adverse events","volume":"23","author":"Kim","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.neurot.2026.e00973_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1673284","article-title":"Toxicity profiles of cyclin-dependent kinase 4\/6 inhibitors: safety analysis from clinical trials and the FDA adverse event reporting system","volume":"15","author":"Zhou","year":"2025","journal-title":"Front Oncol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:07:15Z","timestamp":1790125635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1878747926001431"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00973","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The real-world safety profile of amitriptyline: A comprehensive pharmacovigilance analysis based on the large-scale FDA adverse event reporting system database","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00973"}}